1.上海中医药大学市中医临床医学院(上海 200071)
2.上海中医药大学附属市中医医院妇科(上海 200071)
于晟贇,女,硕士研究生,主要从事中医妇科临床和基础研究工作
宋艳华,副主任医师;E-mail:songyanhua728@163.com
扫 描 看 全 文
于晟贇,宋艳华.中医药治疗非肥胖型多囊卵巢综合征研究进展[J].上海中医药杂志,2023,57(5):87-90.
YU Shengyun,SONG Yanhua.Research progress of traditional Chinese medicine for non⁃obese polycystic ovary syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(5):87-90.
于晟贇,宋艳华.中医药治疗非肥胖型多囊卵巢综合征研究进展[J].上海中医药杂志,2023,57(5):87-90. DOI: 10.16305/j.1007-1334.2023.2205071.
YU Shengyun,SONG Yanhua.Research progress of traditional Chinese medicine for non⁃obese polycystic ovary syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(5):87-90. DOI: 10.16305/j.1007-1334.2023.2205071.
多囊卵巢综合征(PCOS)是育龄期女性常见的一种生殖和内分泌代谢紊乱性疾病,临床表现具有高度异质性,可分为肥胖型和非肥胖型两种表型。有别于肥胖型PCOS,非肥胖型PCOS的关键病理特征为高雄激素血症及相应的临床表现,治疗时应当予以区别。从病因病机、临床研究、作用机制研究3个方面综述中医药治疗非肥胖型PCOS的研究进展。非肥胖型PCOS的核心中医病机是肾虚肝郁,中医药疗法(中药复方、单味中药、针刺)能有效调节非肥胖型PCOS患者的月经周期及性激素水平,增加排卵率,改善多毛、痤疮等高雄激素相关临床表现,提高妊娠率并改善妊娠结局。其机制可能与调节机体肠道菌群、炎症因子、神经生长因子,以及调控下丘脑-垂体-卵巢轴有关。
Polycystic ovary syndrome (PCOS) is a common reproductive and endocrine metabolic disorder in women of childbearing age. Due to a highly heterogeneous clinical presentation, PCOS has two phenotypes: obese and non-obese. Hyperandrogenemia and related clinical manifestations are the key pathological features that distinguish obese PCOS from non-obese PCOS, and treatment should vary accordingly. The research progress of TCM treatment of non-obese PCOS is reviewed from three aspects: etiology and pathogenesis, clinical research, and mechanism research. The core pathogenesis of non-obese PCOS is kidney deficiency and liver depression. Traditional Chinese medicine therapy(herbal formulas, single herbs, and acupuncture) can effectively regulate menstrual cycle and sex hormone levels in non-obese PCOS patients, increase ovulation rate, improve clinical manifestations of hyperandrogenism such as hirsutism and acne, increase pregnancy rate and improve pregnancy outcome. The therapeutic mechanism may be related to the regulation of the body’s gut microbiota, inflammatory cytokines, nerve growth factors, and the hypothalamic-pituitary-ovarian axis.
多囊卵巢综合征高雄激素血症不孕肾虚肝郁证中药针灸肠道菌群
polycystic ovary syndromehyperandrogenemiainfertilitykidney deficiency and liver depression syndrometraditional Chinese herbal medicineacupuncturegut microbiota
YE W, XIE T, SONG Y, et al. The role of androgen and its related signals in PCOS[J]. J Cell Mol Med, 2021, 25(4): 1825-1837.
KHAN M J, ULLAH A, BASIT S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives[J]. Appl Clin Genet, 2019, 12: 249-260.
SANCHEZ-GARRIDO M A, TENA-SEMPERE M. Metabolic dysfun-ction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies[J]. Mol Metab, 2020, 35: 100937.
GONZÁLEZ F. Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction[J]. Semin Reprod Med, 2015, 33(4): 276-286.
ALI A I, NORI W. Correlation of serum visfatin level in non-obese women with polycystic ovary syndrome and matched control[J]. Reprod Sci, 2022, 29(11): 3285-3293.
ROSENFIELD R L, EHRMANN D A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited[J]. Endocr Rev, 2016, 37(5): 467-520.
陆齐天,周一辰,杨冰祎,等. 殷岫绮论治多囊卵巢综合征所致子宫内膜容受性低下经验[J]. 浙江中医药大学学报,2022, 46(2): 142-147.
DAPAS M, LIN F T J, NADKARNI G N, et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis[J]. PLoS Med, 2020, 17(6): e1003132.
俞瑾,俞超芹,侯丽辉,等. 多囊卵巢综合征证治方案研究及应用[J]. 中国中西医结合杂志,2021, 41(2): 246-251.
徐芳,侯丽辉,刘颖华,等. 不同证型多囊卵巢综合征患者的临床和生化特征研究[J]. 现代生物医学进展,2018, 18(8): 1527-1531,1539.
姜文娜,刘畅,孙艺玲,等. 非肥胖型与肥胖型多囊卵巢综合征患者的临床特征及中医证型分布分析[J/OL]. 辽宁中医杂志,2022 [2022-12-06]. http://kns.cnki.net/kcms/detail/21.1128.R.20220816. 0825.015.htmlhttp://kns.cnki.net/kcms/detail/21.1128.R.20220816.0825.015.html.
朱南孙 . 海派中医朱氏妇科[M]. 上海:上海科学技术出版社,2016: 50-51.
徐海飞,张婧,张菁菁,等. 补肾疏肝调周法对多囊卵巢综合征患者卵巢形态与血流动力学的影响[J]. 中国中医药科技,2021, 28(4): 579-580.
林倍倍. 补肾疏肝法治疗多囊卵巢综合征Meta分析[J]. 光明中医,2020, 35(10): 1439-1445.
刘聪,吉楠,党慧敏,等. 调经助孕方治疗肾虚肝郁型多囊卵巢综合征的临床研究[J]. 中国中西医结合杂志,2018, 38(3): 316-320.
刘颖华,刘玲玲,侯丽辉,等. 补肾疏肝调周法治疗多囊卵巢综合征40例[J]. 辽宁中医杂志,2016, 43(7): 1436-1437.
任亚萍. 疏肝补肾汤治疗多囊卵巢综合征不孕不育[J]. 实用中西医结合临床,2021, 21(9): 32-33.
多囊卵巢综合征相关不孕治疗及生育保护共识专家组,中华预防医学会生育力保护分会生殖内分泌生育保护学组. 多囊卵巢综合征相关不孕治疗及生育保护共识[J]. 生殖医学杂志,2020, 29(7): 843-851.
GLINTBORG D, JENSEN R C, BENTSEN K, et al. Testosterone levels in third trimester in polycystic ovary syndrome: odense child cohort[J]. J Clin Endocrinol Metab, 2018, 103(10): 3819-3827.
贺晓霞,游方,刘丽. 不同治疗方案对多囊卵巢综合征不孕患者子宫内膜容受性影响的随机对照研究[J]. 时珍国医国药,2019, 30(10): 2424-2426.
许华云,金毓莉,付金荣,等. 中药人工周期疗法治疗多囊卵巢综合征的Meta分析[J]. 中医药导报,2018, 24(15): 113-117.
盛晓园,宋美铃. 促排助孕汤治疗肾虚肝郁型多囊卵巢综合征并发排卵异常性不孕症的临床疗效[J]. 中国药物与临床,2018, 18(12): 2117-2119.
孟丹. 疏肝补肾汤联合来曲唑治疗多囊卵巢综合征不孕不育症临床观察及对血清孕酮的影响[J]. 中华中医药学刊,2018, 36(2): 507-509.
陈建霞,许宗兰,董保娟,等. 调经固冲汤联合克罗米芬对多囊卵巢综合征不孕患者生殖激素、卵巢形态及卵巢动脉血流动力学的影响[J]. 中国医师杂志,2017, 19(11): 1707-1709.
ABOELDALYL S, JAMES C, SEYAM E, et al. The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis[J]. Int J Mol Sci, 2021, 22(5): 2734.
逯克娜,林寒梅. 肠道菌群与炎症因子参与多囊卵巢综合征的发病机制及中药干预的研究进展[J]. 中华中医药学刊,2021, 40(3): 186-190.
ROSTAMTABAR M, ESMAEILZADEH S, TOURANI M, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome[J]. J Cell Physiol, 2021, 236(2): 824-838.
SHAMSI M, GHAZAVI A, SAEEDIFAR A M, et al. The immune system’s role in PCOS[J]. Mol Biol Rep, 2022, 49(11): 10689-10702.
BARREA L, MARZULLO P, MUSCOGIURI G, et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome[J]. Nutr Res Rev, 2018, 31(2): 291-301.
叶利群,蒋婴,杨脂,等. 滋肾调肝活血调周法联合二甲双胍治疗PCOS的疗效观察及对血清TNF-α、IL-6水平的影响[J]. 中国中医药科技,2018, 25(4): 470-473.
邬春晓,张京春,刘玥,等. 补肾清肝中药配伍对间歇性低氧诱导人脐静脉内皮细胞损伤模型p38MAPK/NF-κB信号通路的干预效应研究[J]. 中国中药杂志,2017, 42(23): 4661-4664.
蒋荣,刘国兵,侯静,等. 黄芩苷对PCOS大鼠体内雌激素、CRP及卵巢组织中caspase-3表达的影响[J]. 遵义医科大学学报,2021, 44(4): 440-445.
ISHFAQ M, ZHANG W, LIU Y, et al. Baicalin attenuated Mycoplasma gallisepticum-induced immune impairment in chicken bursa of fabricius through modulation of autophagy and inhibited inflammation and apoptosis[J]. J Sci Food Agric, 2021, 101(3): 880-890.
杨志友,马智慧,邓嘉航,等.药食同源植物杜仲叶中有效成分京尼平苷酸的抗炎作用研究[J]. 广东化工,2020, 47(22): 47-48,38.
DONG H X, WANG Q, WANG Z, et al. Impact of low frequency electro-acupuncture on glucose and lipid metabolism in unmarried PCOS women: a randomized controlled trial[J]. Chin J Integr Med, 2021, 27(10): 737-743.
STREITER S, FISCH B, SABBAH B, et al. The importance of neuronal growth factors in the ovary[J]. Mol Hum Reprod, 2016, 22(1): 3-17.
ZHAI Y, YAO G, RAO F, et al. Excessive nerve growth factor impairs bidirectional communication between the oocyte and cumulus cells resulting in reduced oocyte competence[J]. Reprod Biol Endocrinol, 2018, 16(1): 28.
MANTI M, PUI H P, EDSTRÖM S, et al. Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice[J]. FASEB J, 2020, 34(11): 14440-14457.
申怡,王静. 针灸调节下丘脑-垂体-卵巢轴治疗多囊卵巢综合征的研究进展[J]. 中国中西医结合杂志,2021, 42(5): 625-632.
梁雨璐,张洁,李忆红,等. 整合网络毒理学和网络药理学的合欢皮抗焦虑毒效机制探究[J]. 药物评价研究,2021, 44(7): 1411-1424.
李灵,陈健,郭炜,等. 基于网络药理学中药郁金治疗抑郁症作用机制研究[J]. 辽宁中医药大学学报,2020, 22(2): 121-125.
QI X, YUN C, SUN L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome[J]. Nat Med, 2019, 25(8): 1225-1233.
SHERMAN S B, SARSOUR N, SALEHI M, et al. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis[J]. Gut Microbes, 2018, 9(5): 400-421.
LEGRO R S, ARSLANIAN S A, EHRMANN D A, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013, 98(12): 4565-4592.
GUO F, GONG Z, FERNANDO T, et al. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population[J]. Front Endocrinol (Lausanne), 2022, 13: 892125.
TANG R, DING X, ZHU J. Kisspeptin and polycystic ovary syndrome[J]. Front Endocrinol (Lausanne), 2019, 10: 298.
雷玲,姚燕,傅毅,等. 多囊卵巢综合征的针刺治疗研究[J]. 世界临床药物,2015, 36(12): 859-863.
CUI P, MA T, TAMADON A, et al. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture[J]. Exp Physiol, 2018, 103(12): 1618-1632.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构